Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 November 2024 | Story Zinzi Zumana | Photo Supplied
UFS X Zambia 2024
UFS and UNZA delegates engaged in a vibrant cultural exchange in Lusaka, Zambia, marking the beginning of a transformative partnership focused on student success, student well-being, and social justice.

The University of the Free State (UFS) and the University of Zambia (UNZA) have embarked on an inspiring international collaboration, with a delegation from the UFS touching down in Lusaka for a week of cross-cultural exchange and educational advancement. This visit – led by the Executive Director of Student Affairs at the UFS, Temba Hlasho – ran from 11 to15 November 2024 and brought together a select group of students and staff to engage in a transformative exchange aimed at strengthening the bonds between these two esteemed institutions.

At the heart of the UFS-UNZA partnership is a shared commitment to holistic student development and social justice. Both institutions seek to cultivate globally minded graduates who are ready to tackle regional and international challenges. The UFS has strategically aligned with UNZA in pursuit of these goals, recognising their compatible institutional visions and their mutual focus on student success, innovation, and building sustainable communities.

In its Strategic Plan for 2027, UNZA emphasises goals of excellence in teaching, research, community service, and digital innovation, while the UFS Vision 130 underscores a dedication to fostering holistic student success. Together, the two institutions are driving forward a vision that merges academic excellence with social responsibility and well-being.

The choice of Zambia as a partner is not accidental. With a deep history of solidarity dating back to the 1980s, South Africa and Zambia share a longstanding cultural connection, now improved by this educational partnership. This visit is rooted in the shared mission to empower the next generation, reinforcing both countries’ commitment to inclusive, thriving educational environments where young people can flourish.

The UFS delegation set out to accomplish several impactful objectives during their time at UNZA, including global collaboration and knowledge exchange, student support and wellness initiatives, commitment to social justice and community engagement, as well as leadership development and academic excellence.

This visit marks the beginning of an exploratory and reciprocal partnership that will extend well beyond the week. Moving forward, the UFS and UNZA will engage in sustained dialogue and collaborative projects across a range of student support initiatives, ensuring that each institution can evolve with new insights and strategies.

As the delegation visit unfolded, both the UFS and UNZA celebrated the dawn of a transformative partnership that bridges borders, unites cultures, and advances a shared vision for student success and social impact. This collaboration is poised to empower students with the skills and perspectives necessary to become leaders in their communities and on the global stage.

Together, the UFS and UNZA are setting a powerful example of international academic partnership, one that promises to foster impactful and lasting change for students, faculty, and the broader society.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept